Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Fu, Zhenfu"'
Autor:
Yan, Fengqin1 (AUTHOR), Fu, Zhenfu1 (AUTHOR), Li, Guo2,3 (AUTHOR) liguo2000@aliyun.com, Wang, Zhiguo4 (AUTHOR) liguo2000@aliyun.com
Publikováno v:
Molecules. Feb2023, Vol. 28 Issue 4, p1829. 22p.
Autor:
Ye, Zhimin, Fang, Jun, Dai, Shujun, Wang, Yuezhen, Fu, Zhenfu, Feng, Wei, Wei, Qichun, Huang, Pintong *
Publikováno v:
In Cancer Letters 28 January 2016 370(2):216-221
Autor:
Wang Fangzheng, Piao Yongfeng, Jiang Yangming, Wang Lei, Fu Zhenfu, Yan Fengqin, Jiang Haitao, Jiang Chuner, Ye Zhimin
Publikováno v:
Oncology Research
The aim of this study was to explore the predictive role of pretreatment MRI-based radiomics on early response of neoadjuvant chemotherapy (NAC) in locoregionally advanced nasopharyngeal carcinoma (NPC) patients. Between January 2016 and December 201
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fangzheng Wang, Jiang Chuner, Piao Yongfeng, Wang Lei, Yan Fengqin, Ye Zhimin, Fu Zhenfu, Jiang Haitao, Wang Yuezhen, Jiang Yangming
Purpose This study aims to investigate survival outcomes and prognostic factors for upward nasopharyngeal carcinoma (NPC) patients receiving radiation therapy (RT) combined with chemotherapy (CT). Methods A total of 421 previously untreated, newly di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02fc1fbe07cecbb21bdae57eb8630908
https://doi.org/10.21203/rs.3.rs-22999/v1
https://doi.org/10.21203/rs.3.rs-22999/v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liu Tongxin, Jiang Yangming, Sun Quanquan, Liu Jiping, Shi Kaiyuan, Jiang Chuner, Wu Peng, Fu Zhenfu, Qin Haiyan, Ye Zhimin, Wang Fangzheng
Publikováno v:
Medicine
Although induction chemotherapy (IC) combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy (CC) is the new standard treatment option in locoregionally advanced nasopharyngeal carcinoma (NPC), many patients fail to receive
Autor:
Jiang Chuner, Liu Tongxin, Yan Fengqin, Wang Fangzheng, Fu Zhenfu, Ye Zhiming, Li Bin, Qin Weifeng, Hu Fujun, Chen Ming, Wang Lei
Publikováno v:
Oncology Research
In this retrospective review of a single institution’s experience, the efficacy and safety of the long-term use of nimotuzumab in combination with intensity-modulated radiotherapy (IMRT) and chemotherapy in the treatment of locally advanced nasopha
Autor:
Shi Kaiyuan, Wang Fangzheng, Liu Tongxin, Liu Jiping, Ye Zhimin, Fu Zhenfu, Sun Quanquan, Masoto Sakamoto, Qin Weifeng, Jiang Chuner, Jiang Yangming, Wu Peng
Publikováno v:
Journal of Cancer
In this study, we examined whether combining neoadjuvant chemotherapy (NAC) and/or concurrent chemotherapy (CC) with intensity-modulated radiotherapy (IMRT) improved survival in patients with stage II nasopharyngeal carcinoma (NPC). Two hundred forty
Autor:
Jiang Chuner, Fu Zhenfu, Wu Peng, Qin Weifeng, Liu Jiping, Sun Quanquan, Jiang Yangming, Wang Fangzheng, Liu Tongxin, Ye Zhimin, Masoto Sakamoto, Shi Kaiyuan
Publikováno v:
Oncotarget
Addition of induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) is a potentially effective approach for treating locoregionally advanced nasopharyngeal carcinoma (NPC). In this study, we compared the efficacy and toxicity of IC regimen